• Home
  • HCN Trends
  • Contact Us

Search Articles

Cardiology Covid-19 Dermatology Endocrinology General Interest Hematology Infectious Disease Neurology Oncology Pediatrics Psychiatry Pulmonology Rheumatology Surgery Uncategorized
acetaminophen actemra adverse events anemia antibody anxiety aspirin azithromycin bipolar disorder bleeding blog brain tumor breast cancer burnout Cancer capecitabine capmatinib cervical cancer chloroquine chronic pain clinical trials cll cloroquine CME compensation core-binding factor coronary artery disease coronavirus cost covid-19 cvd death diagnosis disease doctors dosing drug drug interactions efficacy erlotinib exercise FDA/regulation fever filters fish oil glioblastoma green tea guidelines hemophilia hiv hospital hydroxychloroquine ibrutinib ibuprofen immunity induction chemotherapy infectious disease influenza ipilimumab irinotecan iron-deficiency anemia isn letrozole leukemia Lung cancer malaria malpractice mask Masks mbc MDS medical cannabis medical school Medicine mesothelioma metastatic colorectal cancer methotrexate Myelodysplastic Syndromes myeloid leukemia nivolumab nsclc nursing oil olaparib osimertinib outcomes pandemic patient safety patients pd pediatrics perjeta physicians podcast practice practice management prevention primer procedure prostate cancer radiation recovery remdesivir research/studies respirators respiratory retevmo risk rucaparib sars SARS-CoV-2 infection SCLC selinexor selpercatinib side effects sorafenib stroke Survival/Mortality symptoms syndrome tazemetostat telemedicine testing therapeutics therapy thrombosis thyroid cancer time tnbc tocilizumab trastuzumab trauma treatment tweet vaccine venclexta venetoclax walking wound xpovio

Tag: capmatinib

Haymarket MediaFoundationOne CDx Approved as Companion Diagnostic for Capmatinib for METex14 NSCLC

The approval of capmatinib and its companion diagnostic is the first of its kind for this specific diagnosis, using next-generation sequencing to perform comprehensive genomic profiling of solid tumors. It now has FDA approval for 21 different agents.

Cancercapmatinibnsclc
  • © Healthcare Communications Network
  • Privacy Policy